# GKHT Medical Technology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/gkht-medical-technology-co

- Industry: Medical Devices & Equipment
- Headquarters: Beijing, China
- Website: www.gkht.com
- Total disclosed funding: $155M
- Latest round: Series C (Sep 6, 2019)
- Investors on record: 12

## About

Based in Beijing, China and established in 2013, GKHT Medical Technology Co., Ltd operates as a medical equipment logistic platform and service provider that focuses on orthopedic medical equipment supply. It has established more than 80 subsidiaries nationwide. The company has already become a partner with more than 110 medical device suppliers, including Boston Scientific, Medtronic, Beltran, Abbott, Jetmax, and Stryker. GKHT has obtained ISO9001 and ISO13485 quality certifications, and ISO20000 and ISO27001 information security certifications. In July 2023, GKHT was listed on Shenzhen Stock Exchange.

The company mainly produces orthopedic spinal implant products, orthopedic joint implant products, surgical tools, and intracardiac products, covering more than 90 product lines, including vascular interventions, orthopedic implants, dentistry, ophthalmology, and devices. GKHT also provides users with import, warehousing, bi-directional end-to-end logistics and other related services. The products and services have served more than 2500 dealers and 3600 hospitals nationwide.

The company's revenue is CNY 6.36 billion in 2022.

## Funding rounds

- Series C, Sep 6, 2019, $155M — Legend Capital, CASH Capital, China Merchants Capital, 6 Dimensions Capital, Taikang Life Insurance, Sherpa Healthcare Partners, Longwin Capital, Tibet Yongliu Capital Management
- Series B, Jun 20, 2016 — Legend Capital, NLVC, CASH Capital, Frontline BioVentures, Aeon Life Insurance, Sunland Capital
- Series A, May 28, 2015 — CASH Capital
- Angel, Jan 26, 2015, $0.8M — Sunland Capital

## Investors

- Sunland Capital — Angel, Series B
- CASH Capital (https://capitalatlas.ai/funds/cash-capital) — Series A, Series B, Series C
- Legend Capital — Series B, Series C
- NLVC (https://capitalatlas.ai/funds/nlvc) — Series B
- Frontline BioVentures (https://capitalatlas.ai/funds/frontline-bioventures) — Series B
- Aeon Life Insurance — Series B
- China Merchants Capital (https://capitalatlas.ai/funds/china-merchants-capital) — Series C
- 6 Dimensions Capital (https://capitalatlas.ai/funds/6-dimensions-capital) — Series C
- Taikang Life Insurance — Series C
- Sherpa Healthcare Partners (https://capitalatlas.ai/funds/sherpa-healthcare-partners) — Series C
- Longwin Capital (https://capitalatlas.ai/funds/longwin-capital) — Series C
- Tibet Yongliu Capital Management — Series C